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CRISPR/Cas9-mediated generation 
of a tyrosine hydroxylase reporter 
iPSC line for live imaging and 
isolation of dopaminergic neurons
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Senda Jiménez-Delgado3,5, Mònica Díaz3,5, Jordi soriano-Fradera  6, Graziella Cappelletti  4, 
Javier García-Sancho7, Ángel Raya  3,5,8 & Antonella Consiglio  1,2,9
Patient-specific induced pluripotent stem cells (iPSCs) are a powerful tool to investigate the molecular 
mechanisms underlying Parkinson’s disease (PD), and might provide novel platforms for systematic 
drug screening. Several strategies have been developed to generate iPSC-derived tyrosine hydroxylase 
(TH)-positive dopaminergic neurons (DAn), the clinically relevant cell type in PD; however, they often 
result in mixed neuronal cultures containing only a small proportion of TH-positive DAn. To overcome 
this limitation, we used CRISPR/Cas9-based editing to generate a human iPSC line expressing a 
fluorescent protein (mOrange) knocked-in at the last exon of the TH locus. After differentiation of 
the TH-mOrange reporter iPSC line, we confirmed that mOrange expression faithfully mimicked 
endogenous TH expression in iPSC-derived DAn. We also employed calcium imaging techniques to 
determine the intrinsic functional differences between dopaminergic and non-dopaminergic ventral 
midbrain neurons. Crucially, the brightness of mOrange allowed direct visualization of TH-expressing 
cells in heterogeneous cultures, and enabled us to isolate live mOrange-positive cells through 
fluorescence-activated cell sorting, for further differentiation. This technique, coupled to refined 
imaging and data processing tools, could advance the investigation of PD pathogenesis and might offer 
a platform to test potential new therapeutics for PD and other neurodegenerative diseases.
Parkinson’s disease (PD) is an incurable neurodegenerative disorder in the elderly that is characterized by the 
progressive loss of dopaminergic neurons (DAn) in the substantia nigra pars compacta1. Its incidence in Western 
countries is rising due to the progressive aging of the population, imposing a major burden on national healthcare 
systems. Despite decades of intense research, the pathogenic mechanisms of PD remain unclear owing to the lack 
of experimental models that recapitulate the main features of the disease. The development of induced pluripotent 
stem cell (iPSC) technology has opened new horizons for modeling PD, as iPSCs can be generated from patients’ 
somatic cells and differentiated into disease-relevant cell types, which would capture the genetic complexity of 
PD. Furthermore, human iPSC-derived neuronal models offer unprecedented access to the early stages of the 
disease, allowing the investigation of the events that initiate the pathologic process in PD2,3.
The development of hiPSC-based strategies to treat or model PD, however, is hampered by the lack of efficient 
protocols for the directed differentiation of stem cells into DAn with the appropriate characteristics of A9-subtype 
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ventral midbrain neurons – the neuronal cell type lost in PD (for review, see4). Indeed, although several protocols 
have been developed to differentiate stem cells into functional DAn5–8, the differentiated progeny are a heteroge-
neous mix of DA and non-DA cells, which impedes identifying live DAn. Moreover, the wide variability in terms 
of differentiation ability among different iPSC lines represents a further limitation in the field, which hinders data 
interpretation9–11.
Several strategies have evolved in recent years to overcome these issues, based mainly on the use of DAn 
lineage reporters and, in particular, the expression of tyrosine hydroxylase (TH) – the first and rate-limiting step 
in the synthesis of dopamine – as a marker for identifying DAn12. However, classical approaches relying on the 
expression of a reporter construct controlled by the proximal promoter of the gene of interest have been unsatis-
factory13,14. New gene-editing strategies have been more successful, enabling the insertion of reporter genes under 
the control of endogenous regulatory sequences. In this regard, two recent studies showed that the insertion of 
reporter constructs into the TH gene locus faithfully mimics endogenous TH expression during in vitro and in 
vivo differentiation15,16. But neither of these reporter lines allowed for the direct visualization of TH-positive 
(TH+) neurons in living cells, likely due to the low absolute expression of TH even in DAn.
In the present work, we used a CRISPR/Cas9-based editing strategy to generate a human iPSC line carrying 
the fluorescent protein mOrange knocked-in at the last exon of TH. We first confirmed the exact colocalization of 
mOrange expression from the reporter gene with endogenous TH expression in TH-mOrange hiPSC differenti-
ated into DAn. We then used flow cytometry to evaluate mOrange reporter expression, which could be detected 
as early as 25 days in vitro. Calcium imaging experiments revealed electrophysiological differences between ven-
tral midbrain dopaminergic neurons and non-dopaminergic neurons. This approach also enabled us to isolate 
pure and viable DAn cell populations from heterogeneous cultures. We thus provide a novel cellular model to 
study PD phenotypes in vitro, which may be useful for the implementation of high throughput biological discov-
ery applications including drug target identification.
Results
CRISPR/Cas9-mediated knock-in of a P2A-mOrange cassette in-frame with TH gene. With the 
aim of identifying TH+ neurons among living cells, we generated a genetic reporter construct that could robustly 
and faithfully label DAn. We used CRISPR/Cas9 genome-editing to knock-in a P2A-mOrange fluorescent con-
struct adjacent to the last exon of the TH gene. We chose mOrange because it is one of the brightest monomeric 
fluorescent proteins available17. The designed CRISPR/Cas9 guide RNA spacer sequence overlapped the TH stop 
codon, thereby preventing retargeting of properly edited alleles. The hiPSC line SP_112, generated from a healthy 
control, was co-transfected with the homology-directed repair (HDR) and CRISPR/Cas9 plasmids (Fig. 1A). 
The HDR plasmid contained a LoxP-flanked pRex1-NeoR cassette, allowing selection of recombination events. 
Resistant clones were molecularly characterized and the selection cassette excised (Figs 1B,C and S1). This editing 
approach induced >50% of biallelic integration of the exogenous sequences (data not shown). The edited hiPSC 
line was then expanded and characterized for the expression of pluripotency markers including OCT4, SOX2, 
NANOG, SSEA4, SSEA3 and TRA-1-81, and also karyotype integrity (Fig. 1D,E).
mOrange expression faithfully recapitulates endogenous TH expression in ventral midbrain 
dopaminergic neurons. To differentiate the edited iPSC line towards ventral midbrain DAn (vmDAn), 
we followed a previously published midbrain floor plate differentiation protocol6 (see Methods for details) 
(Fig. 2A,B). Under these conditions, some fluorescent mOrange-positive cells could be observed as early 
as 25 days of differentiation, and the number and the fluorescence intensity of the cells increased over time. 
At day 50 of differentiation, cells were live-imaged (Fig. 2C) and fixed to confirm the fidelity of the reporter. 
Immunofluorescence analysis of fluorescent neurons revealed an absolute correlation between the mOrange 
signal and TH- and mRFP1-immunoreactivity (mOrange is an mRFP1 derivative) (Fig. 2D). By contrast, 
MAP2-positive neurons that were negative for TH immunoreactivity were also negative for mOrange (Fig. 2D), 
confirming the specificity of the transgene in replicating the endogenous TH expression pattern.
Further analysis at day 50 of differentiation demonstrated that ~30% of TH/mOrange-positive cells expressed 
the ventral midbrain forkhead box protein A2 (FOXA2) and, more importantly, the same proportion of cells also 
expressed the A9 domain-specific marker G protein-activated inward rectifier potassium channel 2 (GIRK2) 
(Fig. 2E,G). No differences between TH-mOrange edited and non-edited parental SP_11 iPSC lines were 
observed regarding the expression of vmDAn markers upon differentiation (Fig. 2F,G), indicating that differenti-
ation was not perturbed by the insertion of the transgene.
Overall, our results show that the generated TH-mOrange iPSC line faithfully reports endogenous TH expres-
sion and that the genetic modification does not impair mDA specification.
Ventral midbrain dopaminergic neurons have electrophysiological features distinct from 
non-dopaminergic neurons. The most defining feature of a neuron is its ability to fire action potentials in 
response to neurotransmitters from other neurons. In this regard, we exploited the possibility of identifying live 
DAn to analyze their capability to fire action potentials through studying calcium fluxes. The TH-mOrange iPSC 
line was differentiated towards floor plate derivatives and the resulting neuronal cultures were incubated with 
the calcium sensor Fluo-4 AM and imaged for periods of 30 minutes. Single calcium traces were dichotomized 
depending on whether they were recorded from mOrange+ or mOrange− cells (Fig. 3A,B). Both fluorescent and 
non-fluorescent neurons showed sharp spontaneous increases of Fluo-4 AM signal corresponding to the sudden 
influxes of calcium occurring during bursts (repeated action potentials) (blue arrowheads in Fig. 3B). While both 
groups of neurons showed similar firing patterns, we noted small but significant differences in the amplitude of 
the bursts. At day 35 of differentiation, the amplitude of the burst fired by mOrange− neurons was approximately 
12% larger than those fired by mOrange+ neurons (2.954 ± 0.127 vs 3.296 ± 0.050; p = 0.030). This difference 
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widened to 23% at day 50 of differentiation (2.494 ± 0.106 vs 3.082 +/− 0.090; p = 0.026) (Fig. 3C). These results 
underscore the importance of sampling a homogeneous and defined neuronal population in order to gain resolu-
tion when investigating disease-related phenotypes.
Flow cytometry-based isolation of homogenous populations of mOrange-labeled iPSC 
dopaminergic neurons. To obtain a homogenous population of mOrange-labeled iPSC-derived DAn, 
edited-iPSC DAn were isolated using fluorescence-activated cell sorting (FACS) at 27 days of differentiation. 
For this specific analysis, we utilized an alternative DAn differentiation protocol using dual-SMAD inhibition to 
obtain neural progenitor cells (NPCs) (Fig. S2A, B). With this protocol, NPCs can be expanded in the presence of 
fibroblast growth factor 2 (FGF2) and epidermal growth factor (EGF), cryopreserved, and rapidly differentiated 
into DAn13,18,19. Indeed, when we differentiated the TH-mOrange reporter line using this protocol, mOrange+ 
DAn could be visualized after only seven days of mitogen withdrawal. After 27 days of differentiation, cells were 
mechanically disaggregated, FACS-sorted and subsequently re-seeded on Matrigel-coated plates (Fig. 4A,B). 
Newly extended neurites were readily visible one day after sorting and the neuronal network continued gaining 
complexity over the following days (Fig. 4C,D), therefore that mOrange+ DAn are amenable to FACS-sorting pro-
cedures while remaining viable and maintaining their DA identity. Quantification analysis after immunostaining 
with an antibody to TH confirmed robust DAn purification from the mOrange+ sorted cells (>95% of cells were 
TH/mOrange-double positive). In addition, mOrange-negative sorted cells showed similar levels of mOrange+/
TH+ neurons as the unsorted cells (60.8% vs. 67.5%), suggesting that the mOrange− population contains mitoti-
cally active undifferentiated progenitors or neurons that have not yet switched on TH expression (Fig. 4E). These 
results were confirmed by FACS analysis of the sorted neurons seven days after the initial isolation (Fig. 4B).
Collectively, these results demonstrate that post-mitotic fluorescent DAn can be purified from heterogeneous 
cultures and maintained in culture after sorting.
Discussion
Genetic reporters are extremely useful tools to study signaling and regulatory networks, and offer a potentially 
powerful approach to identify and specifically isolate a cell type of interest from mixed cell populations. They also 
allow live real-time tracking, which provides a more in-depth approach to the study cellular dynamics and fate, 
for example, during the development of cell therapy applications.
Figure 1. Generation of the TH-mOrange reporter iPSC line using CRISPR/Cas9-mediated gene editing. 
(A) Scheme describing the recombination steps during the edition process. Blue arrows represent the primers 
used for the PCR screening procedure. Black triangles represent LoxP sites surrounding the selection cassette. 
(B) Molecular analysis of the correctly targeted clones to confirm proper P2A-mOrange cassette integration 
and selection cassette excision in the control iPSC line. Full-length gels are included in Fig. S1C. (C) Sanger 
sequencing confirmed successful excision of the LoxP site-flanked cassette. (D) Immunofluorescence analysis 
of representative colonies of the TH reporter (SP_11) iPSC line staining positive for the pluripotency-associated 
markers NANOG, OCT4 and SOX2 (green) and TRA-1-81, SSEA3 and SSEA4 (red). Scale bar, 50 µm. (E) 
Normal karyotype of the TH reporter control iPSC line.
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Figure 2. Characterization of ventral midbrain dopaminergic neurons differentiated from the TH-mOrange 
reporter iPSC line. (A) Scheme depicting iPSC differentiation towards floor plate specific ventral midbrain 
dopaminergic neurons (vmDAn). (B) Immunofluorescence analysis of representative floor plate progenitors 
from SP_11 TH reporter iPSCs after 13 days of ventral midbrain patterning staining positive for the floor 
plate markers FOXA2 and EN1 (red), LMX1A and NESTIN (green). Scale bar, 50 µm. (C) Live imaging of 
differentiated TH-mOrange iPSC cell line towards floor plate vmDAn, showing fluorescent neuronal cells after 
50 days of differentiation. (D) Immunofluorescence analysis of DAn differentiated for 50 days and stained 
positive for tyrosine hydroxylase (TH; green), mOrange (red) and MAP2 (grey). Inset show in detail double-
labeled mOrange+/TH+ DAn as well as double negative mOrange−/TH− MAP2+ non-DAn (empty arrowhead) 
confirming faithful reporter activity. Nuclei were counterstained with DAPI. Scale bars 50 µm and 10 µm for 
the large images and the insets respectively. (E) Immunofluorescence analysis of DAn differentiated for 50 days 
and stained for TH and FOXA2 (red and green respectively; left) or GIRK2 and TH (red and green respectively; 
right). Nuclei were counterstained with DAPI. Scale bar, 10 µm both main image and insets. (F) Quantitative 
analysis of the percentage of cells differentiated from either original SP_11 or TH-mOrange iPSC lines stained 
positive for TH. (G) Percentage of TH+ cells stained positive for GIRK2 or FOXA2.
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Here, we used CRISPR/Cas9-based gene editing to generate an iPSC reporter line carrying a copy of 
mOrange under control of the endogenous TH promoter. The mOrange fluorescent construct was preceded by 
a self-excisable 2A peptide sequence and was fused to the last exon of the endogenous TH gene. The engineered 
reporter system was shown to work successfully using two different DAn differentiation protocols. First, using a 
differentiation protocol for floor plate progenitors6, we demonstrated the colocalization of the reporter protein in 
A9 DAn, which are the most vulnerable cells during PD pathogenesis. Secondly, fluorescent DAn were obtained 
after differentiating TH-mOrange hiPSCs to NPCs using dual SMAD inihibtion18. Since earlier attempts to visu-
alize living dopaminergic cells were unsuccessful16, we believe the success of our strategy is based on the excep-
tional brightness of the mOrange protein.
Our ability to identify live dopaminergic neurons allowed us to quantify their electrophysiological activity, an 
important dynamic phenotype. By calcium imaging, we could distinguish very subtle differences in firing patterns 
between mOrange+ and mOrange− neurons. Specifically, we observed that mOrange− neurons exhibited bursts 
of higher amplitude, which directly corresponds to a higher overall activity given the correlation between the 
fluorescence amplitude ∆F/F0 and the number of elicited action potentials20. Accordingly, the ability to sample a 
specific neuronal subtype should help to minimize the variability associated with the differentiation procedure. 
This is crucial when probing subtle and cumulative phenotypes typical of late onset disease such as PD.
Figure 3. Ventral midbrain dopaminergic neurons show intrinsic electrical properties different from ventral 
midbrain non-dopaminergic neurons. (A) Live images in bright field (top picture) and the corresponding 
mOrange and Fluo-4 AM (middle and bottom pictures) fluorescent signal of differentiated neurons (Day 50) 
during calcium imaging. Squares in the bottom picture point to mOrange+ dopaminergic neurons whereas 
circles point to mOrange− non-dopaminergic neurons in which oscillations of Fluo-4 AM fluorescence are 
measured. (B) Calcium traces of selected mOrange+ and mOrange− neurons confirm electrophysiological 
activity. Blue arrowheads point to neuronal firing events. Insets show in detail calcium traces from individual 
mOrange+ or mOrange− neurons. Red line represents an increase in fluorescence equivalent to 3 standard 
deviations (SD) of the mean of the baseline noise. (C) Quantification of the average amplitude of the firing 
events of mOrange+ and mOrange− after 35 and 50 days of differentiation. Data show the average ± S.E.M. of 
two or three independent experiments. At day 35, 130 mOrange+ and 1187 mOrange− cells from 3 independent 
experiments. At day 50, 124 mOrange+ and 1034 mOrange− cells from 2 independent experiments. Asterisk 
denotes statistically significant differences (*p < 0.05).
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Our novel genetic TH reporter system enabled us to successfully isolate and purifiy mOrange+ DAn and later 
resume in vitro culture while preserving their dopaminergic identity. Post-sorted DAn successfully attached to plates 
and extended new neurites in a manner similar to that observed when generating primary neuronal cultures from 
fetal brain. The discordance in TH+ neuron number estimation using cytometry or immunofluorescence is likely 
due to the reduced sensitivity of the former, and the absolute expression of the TH gene would allow for the observa-
tion of those neurons with the highest TH expression. However, a counterweight to this limitation is the standardi-
zation of the sampled (or isolated) neurons, since they most likely represent a defined maturation stage.
In conclusion, we here developed an efficient method for generating TH reporter iPSCs that can be differen-
tiated and sorted to obtain pure dopaminergic neuronal populations without the commonly observed hetero-
geneity of iPSC-derived dopaminergic cultures. We believe that our novel TH reporter tool will facilitate future 
research on the processes associated with specific DAn biology and disease.
Experimental Procedures
Cell culture. The previously generated SP_11 iPSC line (from a healthy control subject) was used, and cells 
were cultured as described2. Briefly, hiPSC were cultured on Matrigel-coated plates (Corning, NY) and main-
tained in human embryonic stem cell medium consisting of KnockOut (KO)-DMEM supplemented with 20% 
KO-Serum Replacement (Gibco/Invitrogen, Carlsbad, CA), 2 mM ultraglutamine, non-essential amino acids and 
Figure 4. mOrange+ DA neurons are amenable to FACS-mediated purification and survive after sorting. (A) 
Experimental procedure followed for FACS-sorting and subsequent re-plating of mOrange+ DAn. (B) Cytograms 
from FACS of mOrange+ cells from differentiated TH-mOrange iPSC. Purified cells were seeded after sorting and 
re-analyzed after 7 days. Cytograms are representative of 2 independent experiments. (C,D) Immunofluorescence 
analysis of mOrange+ DAn sorted and reseeded on Matrigel for 1 (C) and 7 (D) days. One day post-sorting, 
living neurons were first imaged and then fixed and stained with antibodies against TUJ1 (green), TH (grey) and 
mOrange (red). The same combination of antibodies was used to stain neurons cultured for 7 days after sorting. 
Nuclei were counterstained with DAPI. Scale bars, 20 µm and 10 µm for the large image and the inset, respectively. 
(E) Quantitative analysis of the percentage of cells staining positive for TH 7 days after sorting. Data is the 
average ± S.E.M. of two or three independent experiments. Sorted mOrange+ cells, 1232 cells from 2 independent 
experiments; sorted mOrange- cells, 1020 cells from 3 independent experiments; unsorted cells, 679 cells from 2 
independent experiments. Asterisk denotes statistically significant differences (*p < 0.05).
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1% penicillin/streptomycin (all from Lonza), 50 µM 2-mercaptoethanol (Gibco/Invitrogen) and 10 ng/ml bFGF 
(PeproTech, Rocky Hill, NJ), at 37 °C, 5% CO2. The medium was preconditioned overnight by irradiated mouse 
embryonic fibroblasts.
Generation of CRISPR/Cas9 plasmids and donor template for homology-directed repair. The 
CRISPR/Cas9 plasmid pSpCas9(BB)-2A-GFP (PX458) was a gift from Dr. Feng Zhang (Broad Institute, MIT; Addgene 
plasmid #12345)21. The original pCbh promoter was exchanged for the full-length pCAGGS promoter to achieve higher 
expression levels in hiPSCs. Custom guide RNAs were cloned into the BbsI sites as annealed oligonucleotides. The 
donor template for HDR was generated using standard molecular cloning procedures. Briefly, for TH donor template, 
homology arms were amplified from genomic DNA and verified by Sanger sequencing. Resulting sequences matched 
those of the reference genome GRCh38. The homology arms were inserted into the KpnI-ApaI (5′HA) and SpeI-XbaI 
(3′HA) sites of pBS-SK (−). The sequence coding for the P2A peptide was added to mOrange with the primers used to 
amplify the gene and the PCR product was inserted into the ApaI-XhoI sites of the pBS-5′HA-3′HA plasmid. Finally, 
pRex1-Neo-SV40 was inserted between the XhoI and SpeI of the plasmid.
Gene edition in iPSC. To generate the TH-mOrange hiPSC reporter cell line, cells were transfected with 
the HDR template and a Cas9- and gRNA-encoding plasmid; the latter overlapping the TH gene stop codon. In 
total, 800,000 iPSCs were seeded in 10 cm plates the day before transfection. iPSCs were co-transfected with 6 µg 
of CRISPR/Cas9 plasmid and 9 µg HDR template using FuGENE HD (Promega) at a 1:3 DNA to reagent ratio. 
Cells were plated in selection medium containing 50 µg/mL G418 (Melford Laboratories Ltd., Ipswich, UK) and 
maintained for 2 weeks until resistant colonies could be screened. At that time, one-half of each resistant colony 
was manually picked and site-specific integration was verified by PCR.
To excise the selection cassette, edited iPSCs were transfected with a CRE recombinase-expressing plas-
mid, gifted from Dr. Michel Sadelain (Sloan Kettering Institute; Addgene plasmid #27546)22. At 48 hours 
post-transfection, cells were dissociated and seeded at clonal density on a feeder layer of irradiated human fibro-
blasts. When colonies attained a certain size, they were picked and subcultured in independent Matrigel-coated 
wells. Cells were sampled and checked for cassette excision by PCR and Sanger sequencing. Those clones in which 
the cassette was excised were expanded, cryopreserved and karyotyped.
Generation of iPSC-derived ventral midbrain dopaminergic neurons. For the derivation of 
vmDAn, we used a previously published protocol6 with minor modifications. Briefly, iPSCs were maintained in 
mTeSR-1 medium (StemCell Technologies, Vancouver, Canada) until they reached 80% confluence and were then 
cultured in serum replacement medium (day 0) (KO-DMEM, 15% KO serum, 1% non-essential amino acids, 1% 
GlutaMax and 1% penicillin/streptomycin) for an additional 5 days. After that, iPSCs were grown in neurobasal 
medium 1% N2 (17502-048; Gibco/Invitrogen), 2% B27 (17054-044; Gibco/Invitrogen) (N2B27) without vitamin 
A and with 1% penicillin/streptomycin. At day twelve, N2 was removed from the medium until the end of the 
differentiation. The medium was supplemented with SB-431542 (10 mM; day 0–day 5; Sigma-Aldrich, St Louis, 
MI), LDN193189 (100 nM; day 0–day 12; Miltenyi Biotec Inc., San Diego, CA), CHIR99021 (3 mM; day 3–day 
25; Miltenyi), purmorphamine (2 mM; day 1–day 5; Stemgent, Cambridge, MA), Smoothened agonist (1 mM; 
day 1–day 5; Tocris, Bristol, UK), brain-derived neurotropic factor (BDNF) (20 ng/ml; from day 12; Miltenyi), 
glial cell-derived neurotropic factor (GDNF) (20 ng/ml; from day 12; Miltenyi), DAPT (10 mM; from day 12; 
Tocris), db-cAMP (500 mM; from day 12; Sigma-Aldrich), TGFβ3 (1 ng/ml; from day 12; Miltenyi) and ascor-
bic acid (AA, 200 mM; from day 12; Sigma-Aldrich). On day 20, cells were dissociated using Accutase (Merck, 
Kenilworth, NJ), re-plated at 0.75 × 105 cells per cm2 on dishes pre-coated with polyornithine (15 μg/ml), laminin 
(1 μg/ml) and fibronectin (2 μg/ml), and cultured in neurobasal medium with 2% B27 without vitamin A and with 
1% penicillin/streptomycin and trophic factors (GDNF, BDNF, TGFb3, AA, db-cAMP and DAPT) until analy-
sis. Quantification of neurons (at day 35, 50 and 80) was assessed by confocal microscopy using anti-FOXA2, 
anti-MAP2, anti-TH and anti-GIRK2 antibodies.
Generation of human neural progenitor cells. For the generation of NPCs, we followed a previ-
ously published protocol19. Briefly, hiPSC colonies were gently disaggregated from the culture plate and plated 
for 6 hours in non-adherent conditions in DMEM/F12 (Gibco/Invitrogen), 2% B27, 1% N2, 10 μM Y-27632 
(Miltenyl-Biotech), 100 nM LDN-193189 (120-10 C; PeproTech), 10 μM SB431542 (S4317-5MG; Sigma-Aldrich) 
and 2 ng/ml bFGF. Cells were then plated for 10 days on Matrigel-coated dishes in this medium before being 
detached with accutase and re-plated on Matrigel-coated dishes and cultured in neural induction medium: 1:1 
DMEM/F12:neurobasal medium supplemented with 2% B27, 1% N2, 1% ultraglutamine, 10 ng/ml Epidermal 
Growth Factor (EGF; AF-100-15 Peprotech) and 10 ng/ml bFGF. Culturing cells in this neural induction medium 
generates homogenous cultures of NSCs (>95% of the cells).
NPC differentiation to dopaminergic neurons. NSCs were grown at high confluence (70%) for 7 days on 
Matrigel-coated dishes in N2B27 medium supplemented with 200 ng/ml Sonic Hedgehog and 100 ng/ml FGF8 (100-25; 
PreproTech). This first culture step was required to pattern NPCs as DAn progenitors. For terminal differentiation, DAn 
progenitors were plated on polyornitine/laminin-coated dishes in N2B27 medium supplemented with 20 ng/ml BDNF 
(450-02, PeproTech), 20 ng/ml GDNF (450-10, PeproTech), 0.5 mM db-cAMP (A6885-25MG, Sigma-Aldrich) and 5 µM 
DAPT (565770; Calbiochem, San Diego, CA) for the indicated time points.
Immunofluorescence. Cells were fixed with 4% paraformaldehyde in PBS at room temperature for 15 min 
and permeabilized for 15 min in 0.3% Triton X-100 in TBS. Cells were then blocked in Triton X-100 with 3% 
donkey serum for 2 h. The following antibodies were used: goat anti-Nanog (R&D Systems, Minneapolis, MI; 
AF1997; 1:50), mouse IgM anti-Tra-1-81 (Merck-Millipore; MAB4381; 1:200), mouse anti-OCT4 (Santa Cruz 
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Biotechnology, Santa Cruz, CA; sc-5279; 1:30), rat IgM anti-SSEA-3 (Developmental Studies Hybridoma Bank 
[DSHB] Iowa City, IA; MC-631; 1:10), mouse-SOX2 (R&D Systems; MB2018; 1:50), mouse anti-SSEA-4 (DSHB; 
MC-813-70; 1:100), mouse anti-NESTIN (Santa Cruz; sc-23927; 1:300action), rabbit anti-LMX1A (Millipore; 
ab10533; 1:1000), goat anti-EN1 (Santa Cruz; sc-46101; 1:200), mouse anti-TUJ1 (BioLegend, San Diego, CA; 
801202; 1:500), chicken anti-MAP2ab (Abcam ab5392; 1:1000) goat anti-FOXA2 (R&D Systems; AF2400; 1:50), 
rabbit anti-TH (Santa Cruz Biotechnology; sc-14007; 1:500), sheep anti-TH (Pel-Freez Biologicals, Rogers, AR; 
P60101-0 1:500), rabbit anti-mRFP (Abcam, Cambridge, NA; ab34771; 1:400), rabbit anti-GIRK2 (Sigma-Aldrich; 
P8122; 1:40). Secondary antibodies used were the Alexa Fluor Series from Jackson ImmunoResearch Europe 
(Newmarket, UK) (all 1:500). Images were taken using a Leica SP5 confocal microscope. To visualize nuclei, slides 
were stained with 0.5 µg/ml DAPI (4′,6-diamidino-2-phenylindole) and then mounted with polyvinyl alcohol 
with DABCO® (SIGMA).
Calcium Imaging. At days 35 and 50 of differentiation vmDAn were incubated with the calcium indicator 
Fluo-4 AM (Invitrogen) for 30 minutes, with gentle shaking at room temperature. Spontaneous neuronal activ-
ity was monitored for 20 minutes with a CMOS fluorescence camera (Hamamatsu Orca Flash v4; Hamamatsu 
Photonics, Tokyo, Japan) at a rate of 20 images/s and a spatial resolution of 2.3 µm/pixel, which allowed for the 
identification of single neuronal bodies. Data acquisition was controlled through the software Hokawo 2.10 
(Hamamatsu). Data analysis was carried out with the software NETCAL23, which registers the variation of the 
fluorescence signal for each neuron as a function of time, and is directly related with calcium uptake and release. 
The fluorescence signal for each neuron was expressed as ΔF/F0 (%) = 100·(F − F0)/F0, where F0 is the average 
fluorescence value of the neuron at rest.
Neuronal fluorescence traces were next analyzed with NETCAL to infer the timing of neuronal activations. 
The Schmitt trigger method24 was used for inference. This method scans the fluorescence traces for events that 
first pass a high threshold and then remain elevated above a second lower threshold for at least a certain mini-
mum duration. In our analysis, we used +3 standard deviations (SD) of the mean of the baseline noise as the high 
threshold, +2 SD as the low threshold, and 200 ms as the minimum event length.
The series of detected activity events were further contrasted with the fluorescence signal to determine the 
amplitude A of each activity event. The distribution of amplitude values for mOrange+ and mOrange− was then 
computed and the mean and SD values of the distributions finally evaluated.
Statistical analysis. Differences among groups were evaluated by one-way analysis of variance, and com-
parisons between two groups by Student’s t-test, using Prism (Mac OS X). Error bars represent mean ± SEM. A 
p-value less than 0.05 was considered significant.
Study approval. All methods were performed in accordance with the relevant guidelines and regulations. 
The subject from whom iPSC were obtained, gave written informed consent prior to their participation in the 
study. The Commission on Guarantees for Donation and Use of Human Tissues and Cells of the Instituto de Salud 
Carlos III (ISCIII) and the local ethics committee at the Hospital Clínic de Barcelona approved the study, in full 
compliance with Spanish and European laws and regulations.
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